98 related articles for article (PubMed ID: 26810800)
1. Screening Platform toward New Anti-HIV Aptamers Set on Molecular Docking and Fluorescence Quenching Techniques.
Oliviero G; Stornaiuolo M; D'Atri V; Nici F; Yousif AM; D'Errico S; Piccialli G; Mayol L; Novellino E; Marinelli L; Grieco P; Carotenuto A; Noppen S; Liekens S; Balzarini J; Borbone N
Anal Chem; 2016 Feb; 88(4):2327-34. PubMed ID: 26810800
[TBL] [Abstract][Full Text] [Related]
2. Tetra-end-linked oligonucleotides forming DNA G-quadruplexes: a new class of aptamers showing anti-HIV activity.
Oliviero G; Amato J; Borbone N; D'Errico S; Galeone A; Mayol L; Haider S; Olubiyi O; Hoorelbeke B; Balzarini J; Piccialli G
Chem Commun (Camb); 2010 Dec; 46(47):8971-3. PubMed ID: 20972507
[TBL] [Abstract][Full Text] [Related]
3. In silico design of novel broad anti-HIV-1 agents based on glycosphingolipid β-galactosylceramide, a high-affinity receptor for the envelope gp120 V3 loop.
Andrianov AM; Kornoushenko YV; Kashyn IA; Kisel MA; Tuzikov AV
J Biomol Struct Dyn; 2015; 33(5):1051-66. PubMed ID: 24942968
[TBL] [Abstract][Full Text] [Related]
4. Selection, characterization and application of new RNA HIV gp 120 aptamers for facile delivery of Dicer substrate siRNAs into HIV infected cells.
Zhou J; Swiderski P; Li H; Zhang J; Neff CP; Akkina R; Rossi JJ
Nucleic Acids Res; 2009 May; 37(9):3094-109. PubMed ID: 19304999
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, biophysical characterization and anti-HIV activity of d(TG3AG) Quadruplexes bearing hydrophobic tails at the 5'-end.
Romanucci V; Milardi D; Campagna T; Gaglione M; Messere A; D'Urso A; Crisafi E; La Rosa C; Zarrelli A; Balzarini J; Di Fabio G
Bioorg Med Chem; 2014 Feb; 22(3):960-6. PubMed ID: 24433967
[TBL] [Abstract][Full Text] [Related]
6. Hairpin oligonucleotides forming G-quadruplexes: new aptamers with anti-HIV activity.
Romanucci V; Gaglione M; Messere A; Potenza N; Zarrelli A; Noppen S; Liekens S; Balzarini J; Di Fabio G
Eur J Med Chem; 2015 Jan; 89():51-8. PubMed ID: 25462225
[TBL] [Abstract][Full Text] [Related]
7. Anti-HIV activity of new higher order G-quadruplex aptamers obtained from tetra-end-linked oligonucleotides.
Nici F; Oliviero G; Falanga AP; D'Errico S; Marzano M; Musumeci D; Montesarchio D; Noppen S; Pannecouque C; Piccialli G; Borbone N
Org Biomol Chem; 2018 Mar; 16(13):2349-2355. PubMed ID: 29543291
[TBL] [Abstract][Full Text] [Related]
8. Blocking interaction of viral gp120 and CD4-expressing T cells by single-stranded DNA aptamers.
Zhao N; Pei SN; Parekh P; Salazar E; Zu Y
Int J Biochem Cell Biol; 2014 Jun; 51():10-8. PubMed ID: 24661998
[TBL] [Abstract][Full Text] [Related]
9. Computational discovery of novel HIV-1 entry inhibitors based on potent and broad neutralizing antibody VRC01.
Andrianov AM; Kashyn IA; Tuzikov AV
J Mol Graph Model; 2015 Sep; 61():262-71. PubMed ID: 26298811
[TBL] [Abstract][Full Text] [Related]
10. Computational studies identifying entry inhibitor scaffolds targeting the Phe43 cavity of HIV-1 gp120.
Tintori C; Selvaraj M; Badia R; Clotet B; Esté JA; Botta M
ChemMedChem; 2013 Mar; 8(3):475-83. PubMed ID: 23404750
[TBL] [Abstract][Full Text] [Related]
11. Computational design, synthesis and evaluation of new sulphonamide derivatives targeting HIV-1 gp120.
Vangala R; Sivan SK; Peddi SR; Manga V
J Comput Aided Mol Des; 2020 Jan; 34(1):39-54. PubMed ID: 31792886
[TBL] [Abstract][Full Text] [Related]
12. Anti-HIV activity of semisynthetic derivatives of andrographolide and computational study of HIV-1 gp120 protein binding.
Uttekar MM; Das T; Pawar RS; Bhandari B; Menon V; Nutan ; Gupta SK; Bhat SV
Eur J Med Chem; 2012 Oct; 56():368-74. PubMed ID: 22858223
[TBL] [Abstract][Full Text] [Related]
13. Discovery of novel anti-HIV-1 agents based on a broadly neutralizing antibody against the envelope gp120 V3 loop: a computational study.
Andrianov AM; Kashyn IA; Tuzikov AV
J Biomol Struct Dyn; 2014 Dec; 32(12):1993-2004. PubMed ID: 24251545
[TBL] [Abstract][Full Text] [Related]
14. In Silico Selection of Gp120 ssDNA Aptamer to HIV-1.
Sepehri Zarandi H; Behbahani M; Mohabatkar H
SLAS Discov; 2020 Oct; 25(9):1087-1093. PubMed ID: 32452249
[TBL] [Abstract][Full Text] [Related]
15. Molecular docking guided structure based design of symmetrical N,N'-disubstituted urea/thiourea as HIV-1 gp120-CD4 binding inhibitors.
Sivan SK; Vangala R; Manga V
Bioorg Med Chem; 2013 Aug; 21(15):4591-9. PubMed ID: 23777826
[TBL] [Abstract][Full Text] [Related]
16. Rapid screening and identification of active ingredients in licorice extract interacting with V3 loop region of HIV-1 gp120 using ACE and CE-MS.
Li Z; Zhao Y; Lin W; Ye M; Ling X
J Pharm Biomed Anal; 2015; 111():28-35. PubMed ID: 25854854
[TBL] [Abstract][Full Text] [Related]
17. Docking and 3D-QSAR studies of BMS-806 analogs as HIV-1 gp120 entry inhibitors.
Teixeira C; Serradji N; Maurel F; Barbault F
Eur J Med Chem; 2009 Sep; 44(9):3524-32. PubMed ID: 19410340
[TBL] [Abstract][Full Text] [Related]
18. Structural characterization of an anti-gp120 RNA aptamer that neutralizes R5 strains of HIV-1.
Dey AK; Griffiths C; Lea SM; James W
RNA; 2005 Jun; 11(6):873-84. PubMed ID: 15923374
[TBL] [Abstract][Full Text] [Related]
19. Structural characterization of a 2'F-RNA aptamer that binds a HIV-1 SU glycoprotein, gp120.
Sayer N; Ibrahim J; Turner K; Tahiri-Alaoui A; James W
Biochem Biophys Res Commun; 2002 May; 293(3):924-31. PubMed ID: 12051747
[TBL] [Abstract][Full Text] [Related]
20. Discovery of novel anti-HIV active G-quadruplex-forming oligonucleotides.
Di Fabio G; D'Onofrio J; Chiapparelli M; Hoorelbeke B; Montesarchio D; Balzarini J; De Napoli L
Chem Commun (Camb); 2011 Feb; 47(8):2363-5. PubMed ID: 21305065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
